BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10147676)

  • 1. Dry powder inhalers: advantages and limitations.
    Crompton GK
    J Aerosol Med; 1991; 4(3):151-6. PubMed ID: 10147676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol physiology, deposition, and metered dose inhalers.
    Newman SP
    Allergy Proc; 1991; 12(1):41-5. PubMed ID: 2040447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
    Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
    Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulizer possibilities and limitations.
    Matthys H
    J Aerosol Med; 1991; 4(3):157-62. PubMed ID: 10160989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are outcomes the same with all dry powder inhalers?
    Thomas M; Williams AE
    Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
    Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK
    Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices.
    Nimmo CJ; Chen DN; Martinusen SM; Ustad TL; Ostrow DN
    Ann Pharmacother; 1993; 27(7-8):922-7. PubMed ID: 8364279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler.
    Prime D; Grant AC; Slater AL; Woodhouse RN
    J Aerosol Med; 1999; 12(2):75-84. PubMed ID: 10539710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak inspiratory flow through Turbuhaler in acute asthma.
    Brown PH; Ning AC; Greening AP; McLean A; Crompton GK
    Eur Respir J; 1995 Nov; 8(11):1940-1. PubMed ID: 8620966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
    Donnell D
    Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a spacer device used with metered dose inhaler].
    Hidemitsu ; Mohri ; Higuchi K; Kanazawa T; Ohkawara M; Yuki T; Kobayashi H; Tamura M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1415-20. PubMed ID: 2290224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.